Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1094 of 6351
-
Can meditation rewire the anxious social brain?
Symptom relief CompletedThe purpose of this study is to develop and test a mindfulness and loving-kindness based intervention, Positive Affect Training (PAT), to enhance positive affect such as compassion, love, and gratitude and reduce symptoms of social anxiety disorder (SAD). PAT involves a combinati…
Sponsor: Komazawa University • Aim: Symptom relief
Last updated Aug 30, 2026 00:00 UTC
-
Could a diabetes drug help leukemia patients stay off cancer pills?
Disease control Recruiting nowSingle-center study, prospective, phase II trial. The study objectives are : * To assess safety and pharmacokinetics of the combination of PIO and TKI in CML subjects who experience a loss of MMR following a first TKI discontinuation. * To assess survival without loss of MMR ov…
Phase 2 • Sponsor: Versailles Hospital • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New drug shows promise in preventing transplant complication
Prevention CompletedThis research study is studying a drug called obinutuzumab as a means of preventing chronic Graft vs. Host Disease (cGVHD).
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Prevention
Last updated Jun 27, 2026 09:05 UTC
-
Shock therapy: can a heart device save lives in rare angina?
Disease control Recruiting nowThe purpose of this study is to determine whether ICD(Implantable Cardioverter Defibrillator) implantation on the top of optimal medical therapy in patients with variant angina manifesting as aborted sudden cardiac death reduces the incidence of the death from any cause compared …
Phase 4 • Sponsor: Kee-joon Choi • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could a drug cocktail halt bone Cancer's spread after radiation?
Disease control Stopped earlyThis randomized phase III trial compares ixazomib citrate, lenalidomide, dexamethasone and zoledronic acid with zoledronic acid alone to see how well they work when given after radiation therapy in treating patients with solitary plasmacytoma of bone. Ixazomib citrate may stop th…
Phase 3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New heart valve design aims to simplify replacements and cut risks
Disease control Recruiting nowThe study of new biological heart valves with the "easy change" system, including an assessment of the basic hemodynamic characteristics of the prosthesis, complications associated with valve implantation, and general mortality
Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New drug combo aims to keep mantle cell lymphoma in check
Disease control CompletedThis study is a multicentric, single arm phase II trial to evaluate the efficacy of upfront obinutuzumab in mantle cell lymphoma patients treated by Cisplatinum-Cytarabine-Dexamethasone (DHAP) followed by autologous transplantation plus obinutuzumab maintenance then Molecular Res…
Phase 2 • Sponsor: The Lymphoma Academic Research Organisation • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Can a single drug dose forecast transplant kidney health?
Knowledge-focused CompletedFurosemide is an old drug that has been used frequently in the postoperative period of kidney transplantation, aiming to achieve adequate urine output. There is no previous study that directly evaluate the urine response to standardized dose of furosemide in the postoperative per…
Sponsor: King Chulalongkorn Memorial Hospital • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
Can a gene test guide better treatment for head and neck cancer survivors?
Disease control Recruiting nowThis phase II trial studies how well radiation therapy with or without cisplatin works in treating patients with stage III-IVA squamous cell carcinoma of the head and neck who have undergone surgery. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors.…
Phase 2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Experimental combo shows promise for Tough-to-Treat cancers
Disease control OngoingThis is a multi-cohort single arm phase II/screening trial of the combination of a fusion protein that binds EphrinB2 and blocks interaction with cell surface EphB receptors (sEphB4-HSA) in combination with an anti-PD1 antibody (MK-7435 / Pembrolizumab) for treatment of patients …
Phase 2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New immunotherapy shows promise against multiple advanced cancers
Disease control OngoingThe Primary purpose of this study is to identify the recommended Phase 2 dose \[RP2D(s)\] for JNJ-63723283 in Part 1, to assess the anti-tumor activity of JNJ-63723283 at the RP2D(s) in participants with selected advanced cancers including non-small-cell lung cancer (NSCLC), mela…
Phase 1/2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Immune cells and drugs injected directly into brain tumor in new trial
Disease control OngoingPhase I/II clinical trial on the per-operative intra-tumoral administration of myeloid dendritic cells plus ipilimumab and nivolumab, followed by repeated intracavitary administration of ipilimumab and nivolumab plus intravenous administration of nivolumab in patients with recurr…
Phase 1/2 • Sponsor: Universitair Ziekenhuis Brussel • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New cocktail of drugs takes on Hard-to-Treat prostate cancer
Disease control OngoingThe purpose of this study is to assess the safety and efficacy of pembrolizumab (MK-3475) combination therapy in participants with metastatic castration resistant prostate cancer (mCRPC). There will be ten cohorts in this study: Cohort A will receive pembrolizumab + olaparib, Coh…
Phase 1/2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New drug cocktail shows promise for recurrent ovarian cancer
Disease control OngoingThis research study is evaluating three drugs called Nivolumab, Bevacizumab, and Rucaparib as a possible treatment for relapsed Relapsed Ovarian, Fallopian Tube Or Peritoneal Cancer.
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New device aims to fix leaky heart valves without stopping the heart
Disease control OngoingThe objective of this trial is to assess the safety and effectiveness of the study device in subjects with degenerative mitral valve disease receiving a mitral valve repair without cardiopulmonary bypass (treatment group) when compared to subjects receiving mitral valve repair us…
Sponsor: NeoChord • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Common heart drug may shield eyes of type 1 diabetes patients
Disease control OngoingThe purpose of this study is to evaluate the potential benefits of 145 mg of daily fenofibrate in adults with type 1 diabetes mellitus and pre-existing non-proliferative diabetic retinopathy.
Phase 3 • Sponsor: University of Sydney • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New hope for tough breast cancer: drug cocktail targets resistant tumors
Disease control CompletedThis phase II trial studies how well panitumumab, carboplatin and paclitaxel work in treating patients with newly diagnosed triple negative breast cancer that is limited to the breast and possibly to the nearby lymph nodes (locally advanced). This treatment study is linked to NCI…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New hope for kids with rare immune disorder: international trial tests drug cocktails
Disease control OngoingThe LCH-IV is an international, multicenter, prospective clinical study for pediatric Langerhans Cell Histiocytosis LCH (age \< 18 years).
Phase 2/3 • Sponsor: North American Consortium for Histiocytosis • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Brittle bone breakthrough? new drug combo aims to cut fractures
Disease control CompletedOsteogenesis imperfecta (OI) is an inherited skeletal disorder characterised by increased risk of fragility fractures. Bisphosphonates are frequently prescribed for adult patients with OI with the aim of preventing fractures but the evidence base for efficacy is poor. Recent evid…
Phase 4 • Sponsor: University of Edinburgh • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Could a cholesterol drug boost reading skills in kids with NF1?
Disease control OngoingNeurofibromatosis Type 1 (NF1) is a common genetic disorder that is associated with a four times greater risk of learning disabilities, including reading disabilities, and a deficiency of neurofibromin - a protein important in a signaling pathway that regulates learning and memor…
Phase 2 • Sponsor: Vanderbilt University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC